Open Access
Vis Cancer Med
Volume 5, 2024
Article Number 2
Number of page(s) 9
Published online 09 February 2024
  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424. [CrossRef] [PubMed] [Google Scholar]
  2. Chabner BA, Roberts TG. Chemotherapy and the war on cancer. Nature Reviews Cancer. 2005;5(1):65–72. [CrossRef] [PubMed] [Google Scholar]
  3. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. Journal of the National Cancer Institute. 2010;102(1):14–25. [CrossRef] [PubMed] [Google Scholar]
  4. Dempsey JL, Seshadri RS, Morley AA. Increased mutation frequency following treatment with cancer chemotherapy. Cancer Research. 1985;45(6):2873–7. [PubMed] [Google Scholar]
  5. Advani PG, Schonfeld SJ, Curtis RE, Dores GM, Linet MS, Sigel BS, et al. Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study. Leukemia. 2019;33(12):2947–78. [CrossRef] [PubMed] [Google Scholar]
  6. Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, et al. Duration of adjuvant chemotherapy for stage III colon cancer. New England Journal of Medicine. 2018;378(13):1177–88. [CrossRef] [PubMed] [Google Scholar]
  7. Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–54. [CrossRef] [PubMed] [Google Scholar]
  8. Proto C, Ferrara R, Signorelli D, Lo Russo G, Galli G, Imbimbo M, et al. Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): What to add and what to leave out. 2019;75:39–51. [Google Scholar]
  9. Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, et al. Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer. Cancer Cell. 2018;33(5):843–852.e4. [CrossRef] [PubMed] [Google Scholar]
  10. Pillai RN, Behera M, Owonikoko TK, Kamphorst AO, Pakkala S, Belani CP, et al. Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature. Cancer. 2018;124(2):271–7. [CrossRef] [PubMed] [Google Scholar]
  11. Parker MS, Groves RC, Fowler AA, Shepherd RW, Cassano AD, Cafaro PL, et al. Lung cancer screening with low-dose computed tomography: an analysis of the MEDCAC decision. Journal of Thoracic Imaging. 2015;30(1):15–23. [CrossRef] [PubMed] [Google Scholar]
  12. Yao S, Jin B, Liu Z, Shao C, Zhao R, Wang X, et al. Biomineralization: from material tactics to biological strategy. Advanced Materials. 2017;29(14):1605903. [CrossRef] [Google Scholar]
  13. Wang W, Liu X, Zheng X, Jin HJ, Li X. Biomineralization: an opportunity and challenge of nanoparticle drug delivery systems for cancer therapy. Advanced Healthcare Materials. 2020;9(22):e2001117. [CrossRef] [PubMed] [Google Scholar]
  14. Sharma V, Srinivasan A, Nikolajeff F, Kumar S. Biomineralization process in hard tissues: The interaction complexity within protein and inorganic counterparts. Acta Biomaterialia. 2021J;15(120):20–37. [PubMed] [Google Scholar]
  15. Zhang Y, Zhou YJ, Lin JP, Chen GL, Liaw PK. Solid-solution phase formation rules for multi-component alloys. Advanced Engineering Materials. 2008;10(6):534–8. [CrossRef] [Google Scholar]
  16. Nakanishi K, Nakagawa K, Asakura K, Yoshida Y, Watanabe H, Watanabe SI. Is calcification in the regional lymph nodes a benign feature in patients with lung cancer? World Journal of Surgery. 2019;43(7):1850–6. [CrossRef] [PubMed] [Google Scholar]
  17. Sumi T, Uehara H, Masaoka T, Tada M, Keira Y, Kamada K, et al. Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: A case report. 2020;11(11):3396–400. [Google Scholar]
  18. Weigel S, Decker T, Korsching E, Hungermann D, Böcker W, Heindel W. Calcifications in digital mammographic screening: improvement of early detection of invasive breast cancers? Radiology. 2010;255(3):738–45. [CrossRef] [PubMed] [Google Scholar]
  19. Cox RF, Morgan MP. Microcalcifications in breast cancer: Lessons from physiological mineralization. Bone. 2013;53(2):437–50. [CrossRef] [PubMed] [Google Scholar]
  20. Samart P, Luanpitpong S, Rojanasakul Y, Issaragrisil S. O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination. Journal of Experimental & Clinical Cancer Research. 2021;40(1):100. [CrossRef] [PubMed] [Google Scholar]
  21. Walser M. The separate effects of hyperparathyroidism, hypercalcemia of malignancy, renal failure, and acidosis on the state of calcium, phosphate, and other ions in plasma. Journal of Clinical Investigation. 1962;41(7):1454–71. [CrossRef] [PubMed] [Google Scholar]
  22. Konhauser KO. Diversity of bacterial iron mineralization. Earth-Science Reviews. 1998;43(3):91–121. [CrossRef] [Google Scholar]
  23. Tang N, Li H, Zhang L, Zhang X, Chen Y, Shou H, et al. A macromolecular drug for cancer therapy via extracellular calcification. Angewandte Chemie International Edition. 2021;60(12):6509–17. [CrossRef] [PubMed] [Google Scholar]
  24. Wu J, Chen Y, Xin J, Qin J, Zheng W, Feng S, et al. Bioinspired tumor calcification enables early detection and elimination of lung cancer. Advanced Functional Materials. 2021;31(27):2101284. [CrossRef] [Google Scholar]
  25. Zhang K, Wu J, Zhao X, Qin J, Xue Y, Zheng W, et al. Prussian blue/calcium peroxide nanocomposites-mediated tumor cell iron mineralization for treatment of experimental lung adenocarcinoma. ACS Nano. 2021;15(12):19838–52. [CrossRef] [PubMed] [Google Scholar]
  26. Boyan BD, Boskey AL. Co-isolation of proteolipids and calcium-phospholipid-phosphate complexes. Calcified Tissue International. 1984;36(2):214–8. [CrossRef] [PubMed] [Google Scholar]
  27. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nature Reviews Cardiology. 2010;7(9):528–36. [CrossRef] [PubMed] [Google Scholar]
  28. Bazin D, Daudon M, Combes C, Rey C. Characterization and some physicochemical aspects of pathological microcalcifications. Chemical Reviews. 2012;112(10):5092–120. [CrossRef] [PubMed] [Google Scholar]
  29. Kim HC, Joo I, Lee M, Kim YJ, Paeng JC, Chung JW. Radioembolization-induced tumor calcifications as a surrogate marker of tumor response in patients with hepatocellular carcinoma. Anticancer Research. 2020;40(7):4191–8. [CrossRef] [PubMed] [Google Scholar]
  30. Zhou Y, Zhang J, et al. Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancer. Anticancer Drug. 2019;30(2):195–200. [CrossRef] [PubMed] [Google Scholar]
  31. Wang B, Liu P, Jiang W, Pan H, Xu X, Tang R. Yeast cells with an artificial mineral shell: protection and modification of living cells by biomimetic mineralization. Angewandte Chemie International Edition. 2008;47(19):3560–4. [CrossRef] [PubMed] [Google Scholar]
  32. Veronesi G, Bellomi M, Mulshine JL, Pelosi G, Scanagatta P, Paganelli G, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008;61(3):340–9. [CrossRef] [PubMed] [Google Scholar]
  33. Chang DK, Lin CT, Wu CH, Wu HC. A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer. PLoS One. 2009;4(1):e4171. [CrossRef] [PubMed] [Google Scholar]
  34. Garin-Chesa P, Campbell I, Saigo PE, Lewis JL, Old LJ, Rettig WJ. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. American Journal of Pathology. 1993;142(2):557–67. [Google Scholar]
  35. Elnakat H, Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: Implications in targeted therapy. Advanced Drug Delivery Reviews. 2004;56(8):1067–84. [CrossRef] [PubMed] [Google Scholar]
  36. Evans JS. “Tuning in” to mollusk shell nacre- and prismatic-associated protein terminal sequences. Implications for biomineralization and the construction of high performance inorganic−organic composites. Chemical Reviews. 2008;108(11):4455–62. [CrossRef] [PubMed] [Google Scholar]
  37. Addadi L, Weiner S. Interactions between acidic proteins and crystals: Stereochemical requirements in biomineralization. PNAS. 1985;82(12):4110–4. [CrossRef] [PubMed] [Google Scholar]
  38. Arias JL, Fernández MS. Polysaccharides and proteoglycans in calcium carbonate-based biomineralization. Chemical Reviews. 2008;108(11):4475–82. [CrossRef] [PubMed] [Google Scholar]
  39. Tsuji T, Onuma K, Yamamoto A, Iijima M, Shiba K. Direct transformation from amorphous to crystalline calcium phosphate facilitated by motif-programmed artificial proteins. PNAS. 2008;105(44):16866–70. [CrossRef] [PubMed] [Google Scholar]
  40. Zhao R, Wang B, Yang X, Xiao Y, Wang X, Shao C, et al. A drug-free tumor therapy strategy: cancer-cell-targeting calcification. Angewandte Chemie International Edition. 2016;55(17):5225–9. [CrossRef] [PubMed] [Google Scholar]
  41. Shou H, Wu J, Tang N, Wang B. Calcification-based cancer diagnosis and therapy. ChemMedChem. 2022;17(4):e202100339. [CrossRef] [PubMed] [Google Scholar]
  42. Xiong W, Yang Z, Zhai H, Wang G, Xu X, Ma W, et al. Alleviation of high light-induced photoinhibition in cyanobacteria by artificially conferred biosilica shells. Chemical Communications. 2013;49(68):7525–7. [CrossRef] [PubMed] [Google Scholar]
  43. Shenton W, Douglas T, Young M, Stubbs G, Mann S. Inorganic-organic nanotube composites from template mineralization of tobacco mosaic virus. Advanced Materials. 1999;11(3):253–6. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.